Resolvins Decrease Oxidative Stress Mediated Macrophage and Epithelial Cell Interaction through Decreased Cytokine...

Area of Science:

• Pulmonary Medicine
• Inflammation Research
• Cell Biology

Background:

• Acute lung injury (ALI) is characterized by inflammation driven by cytokine signaling, particularly interleukin-1beta (IL-1β).
• Macrophages secrete IL-1β, activating alveolar epithelial cells and leading to barrier dysfunction and leukocyte adhesion.
• Endogenous resolution mechanisms for IL-1β-mediated inflammation in ALI are not well understood.

Purpose of the Study:

• To investigate the protective effects of Aspirin-Triggered Resolvin D1 (AT-RvD1) in resolving IL-1β-induced inflammation in ALI.
• To determine if AT-RvD1 can reduce IL-1β secretion by macrophages and subsequent alveolar epithelial cell activation.

Main Methods:

• THP-1 macrophages were stimulated with H2O2 and ATP, with or without AT-RvD1, to assess IL-1β production.
• A549 alveolar epithelial cells were treated with IL-1β, with or without AT-RvD1, to evaluate inflammatory responses.
• Western blot, qPCR, and ELISA were used to analyze pro-inflammatory molecules, adhesion molecules, and signaling pathways.

Main Results:

• AT-RvD1 significantly decreased IL-1β production and activity in stimulated macrophages.
• In A549 cells, AT-RvD1 reduced IL-1β-induced secretion of IL-6 and IL-8.
• AT-RvD1 treatment decreased IL-1β-mediated adhesion molecule expression, leukocyte adhesion, and MAP-Kinase signaling.

Conclusions:

• AT-RvD1 effectively reduces IL-1β secretion from macrophages and subsequent IL-1β-mediated alveolar epithelial cell activation.
• These findings suggest AT-RvD1 has significant pro-resolutionary potential in ALI by mitigating key inflammatory pathways.
• AT-RvD1 represents a promising therapeutic target for resolving inflammation in acute lung injury.